CROs can look forward to “steady but tentative growth” in the coming years, but the biggest gainers will be the largest companies in the business, with the…

As both healthcare data and consultancy firm IMS Health and Quintiles, the world’s largest CRO, begin the process of becoming one giant $19 billion entity, the…

The Asian unit of perpetual life science backer OrbiMed has led a modest $9.7 million first round for biotech CBT Pharmaceuticals as it looks to build up its c…

Fresh off the $1.25 billion Flexus sale, Terry Rosen is aiming to build a major immuno-oncology biopharma from the ground up with upstart Arcus Biosciences.

Ferring Pharmaceuticals has secured the rights to a Phase III treatment of radicular leg pain outside of Japan from Seikagaku.

Since Celyad failed to reach its primary endpoints in a stem cell therapy test in heart patients back in June, CardioCell has felt the pressure to deliver and…

A Stanford University spinout that lists Johnson & Johnson, Novartis and Pfizer among its users has raised $10 million to develop its brain mapping…

After rejecting Abbott’s $50 million breakup offer in April, Alere is now suing the devicemaker in a bid to force it to complete the acquisition.